The Board

Appointed Group Chief Executive in April 2016. He was previously an executive Director and Head of Investment from May 2014.
Experience: He began his career at Schroders and subsequently held roles at Newton Investment Management, JP Morgan Asset Management as Head of Global Equities and Multi-Asset and at Deutsche Asset Management as Global Chief Investment Officer. He was Chairman and Chief Executive of RWC Partners before re-joining Schroders as Global Head of Equities in March 2013.
External appointments: Chairman of the Investment Association, a Director of FCLT Global, a member of the Takeover Panel, and on the advisory boards of the Diversity Project, CFA and CityUK.

Appointed a Director and Chief Financial Officer in May 2013.
Experience: He is a chartered accountant and was a senior audit partner of PricewaterhouseCoopers LLP (PwC) until May 2013. He became a partner of PwC in 1997 and has 25 years’ experience in the audits of global financial services groups. His experience includes time spent in PwC’s New York, Sydney, Edinburgh and London offices.
External appointments: Non-executive member of Lloyd’s Franchise Board and Chairman of its Audit Committee.

Appointed Chairman in April 2016, having been Chief Executive since November 2001. He first joined the Board as a non-executive Director in April 2001.
Experience: Prior to joining Schroders he was Chief Executive of Morgan Grenfell Group and a member of the Board of Managing Directors of Deutsche Bank AG.
External appointments: Member of the President’s Committee of the Confederation of British Industry.
Committee membership: Chairman of the Nominations Committee.

Appointed as a non-executive Director in January 2017, and as Senior Independent Director in April 2018. 
Experience: He was the Chief Executive of BAE Systems plc from 2008 to 2017 having been originally appointed to the BAE board as Chief Operating Officer, UK and Rest of the World. Prior to this, he was Chief Executive of Alenia Marconi Systems. He also served as a non-executive Director and Senior Independent Director of Rotork plc until June 2014.
External appointments: Senior Adviser to the Board of Gleacher Shacklock LLP, Chairman-designate of Senior plc and lead non-executive Director for the Department of Transport.
Committee membership: Member of the Nominations and Remuneration Committees.

Appointed in March 2010.
Experience: He was the Senior Partner of Bain & Company Inc. in the UK for 12 years and remains a Senior Adviser. Most recently he served as Chairman of PageGroup plc until December 2015. He was Dean and President of London Business School. He is a chartered accountant and holds an MBA from Harvard Business School.
External appointments: Non-executive Director of LyondellBasell Industries N.V. He is Chairman of the Advisory Board of Access Industries, and a Director of CICAP Limited.
Committee membership: Member of the Nominations, Audit and Risk, and Remuneration Committees.

Appointed in February 2018.
Experience: He has over 25 years’ experience in private equity, joining Schroder Ventures in 1988. He was Managing Partner of Permira from 1997 to 2007 before becoming Chairman. He retired in 2015 and remains a Senior Adviser.
External appointments: Chairman of the National Theatre, Senior Independent Director of the PGA Tour and was Chairman of the Government's Patient Capital Review.
Committee membership: Member of the Nominations and Remuneration Committees.

Appointed in July 2015.
Experience: She is a chartered accountant and was a partner at Electra Partners, an independent private equity fund manager until June 2015 and then a senior adviser until March 2017. She previously worked in PwC’s audit and insolvency practice before joining Electra in 1992.
Committee membership: Chairman of the Audit and Risk Committee. Member of the Nominations Committee.

Appointed in January 2017. 
Experience: She is an experienced executive in digital retailing having spent 11 years at Amazon. Prior to joining Amazon, she held roles at TomTom and in management consultancy in the US.
External appointments: Non-executive Director of Kingfisher plc, Rightmove plc and Intu Properties plc.
Committee membership: Member of the Nominations and Audit and Risk Committees.

Appointed an executive Director in January 2009 and a non-executive Director on 1 March 2017.
Experience: He started his career with Credit Suisse First Boston in 1985. He first joined Schroders in 1994, and then worked for Citigroup from 2000 to 2002. He rejoined Schroders in 2002 as Head of Corporate Development, was Group Head of Wealth Management from 2006 to 2016 and then Group Head of Private Assets and Wealth Management until 1 March 2017.
External appointments: Non-executive Director of The Economist and a member of the International Advisory Council of the Brookings Institution.
Committee membership: Member of the Nominations Committee.

Appointed in September 2012. 
Experience: She has over 30 years’ experience in the asset management and stock broking industries. She was the Chief Executive and then Deputy Chairman of J O Hambro Capital Management Ltd from 1998 until 2008, following which she held a number of roles in the charity and public sectors.
External appointments: Founder and Chairman of Investment 2020 and a Member of the Eton College Investment Committee. 
Committee membership: Chairman of the Remuneration Committee, Member of the Nominations and Audit and Risk Committee.

Appointed in March 2019.
Experience: She is a descendant of John Henry Schroder, co-founder of Schroders in 1804. She has held a number of roles in the charity sector.
External appointments: Director of the Schroder Charity Trust and a number of private limited companies.
Committee membership: Member of the Nominations Committee.

Appointed in March 2019. 
Experience: She has been the CEO of Viiv Healthcare since 2017. ViiV Healthcare is a leading global company, majority owned by GlaxoSmithKline and focused on advancing science into HIV treatment, prevention and care. In 2018 ViiV Healthcare generated sales of £4.7 billion. She has more than two decades of experience in the pharmaceuticals sector.
Committee membership: Member of the Nominations Committee.